# Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-ii-evaluation-of-nivolumab-in-the-treatment-of-persistent-or-recurrent/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alessandro D. Santin,Wei Deng,Michael Frumovitz,Natália Buza,Stefania Bellone,Warner K. Huh,Samir N. Khleif,Heather A. Lankes,Elena Ratner,Roisin E. O’Cearbhaill,Amir A. Jazaeri,Michael J. Birrer |
| Citations | 155 |
| DOI | 10.1016/j.ygyno.2019.12.034 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/7127981 |
| OpenAlex ID | https://openalex.org/W3000736809 |
| PMID | 31924334 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Wei Deng](https://scholariq.org/researchers/wei-deng/)
- [Roisin E. O’Cearbhaill](https://scholariq.org/researchers/roisin-e-o-cearbhaill/)

## Paper journal

- [Gynecologic Oncology](https://scholariq.org/journals/gynecologic-oncology/)

## Paper primary topic

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)

## Paper topics

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.